COVID-19: Nationalism & Exceptionalism Undermines Global Health
Ethics Grand Rounds:
The COVID-19 pandemic is the most serious public health threat the world has faced in the last century. As rich and powerful countries dedicate significant resources to producing efficacious vaccines and treatments for their citizens, billions of people in low and middle income countries risk getting left behind. As COVID-19 is a global pandemic, our response to the pandemic should account for social and economic disparities at national, regional and global levels. Nationalism and exceptionalism will only amplify global health inequities and should be resisted. For this talk, Jerome Singh, BA, LLB, LLM, MHSc, PhD, a professor of clinical public health, discusses the global health equity issues connected to COVID-19.
This was an event of the Office of Academic Clinical Affairs (OACA) hosted by the Center for Bioethics and created in partnership by the following University of Minnesota units: the School of Nursing, the School of Public Health, and the Center for Global Health & Social Responsibility.
Jerome Singh, BA, LLB, LLM, MHSc, PhD, Adjunct Professor of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Canada | Professor Singh is also the Director of the Ethical, Legal, and Social Issues (ELSI) Advisory Services on Global Health Research and Development and serves as an ad hoc Consultant to several UN entities, including the WHO, UNAIDS, UNICEF, the Special Programme for Research and Training in Tropical Diseases (WHO-TDR), and the United Nations Interregional Crime and Justice Research Institute (UNICRI). He is the Co-Chairperson of the NIH-sponsored HIV Prevention Trial Network’s (HPTN) Ethics Working Group, and a member of the NIH-sponsored HIV Vaccine Trial Network’s (HVTN) Efficacy Trial Working Group. He currently serves on several oversight bodies, including the International Ethics Review Board of Médecins Sans Frontières (MSF) and the World Health Organisation’s Ad Hoc Research Ethics Review Committee for COVID-19.